StanDerm

Welcome to the official website of COST Action TD1206 "StanDerm"

About the Action

 

Action Chair

Prof. Swen Malte John
Institute for interdisciplinary Dermatological Prevention
and Rehabiliation,
University of Osnabrück, Department of Dermatology,
Environmental Medicine and Health Theory
Am Finkenhügel 7a
49076 Osnabrück, Germany
Fax: (0049) (0) 541 969 2445
Phone: (0049) (0) 541 969 2357
sjohn(at)uos.de
www.iderm.de | www.dermatologie.uni-osnabrueck.de 

Action Vice Chair

Dr. Sanja Kezic
Academic Medical Center
Meibergdreef 15
1100 AZ Amsterdam, Netherlands
Phone: (0031) (020) 566 5321
s.kezic(at)amc.uva.nl 

Action Science Officer

Estelle Emeriau
COST Office
Avenue Louise 149
1050 Brussels, Belgium
Fax: 0032 (0) 2 533 38 90
Phone: 0032 (0) 2 533 38 68
estelle.emeriau(at)cost.eu

Find the relevant COST Office website describing the Action.

Our funding is through COST (European Cooperation in Science and Technology)

News

OSH World Congress 2017 Singapore

26 June 2017 | StanDerm's OSD position paper accepted

Great news: StanDerm’s postion paper „Minimum Standards on Prevention, Diagnosis and Treatment of Occupational and Work-related Skin Diseases in Europe“ has been accepted as oral presentation at the leading global occupational safety and health congress XXI World Congress on Safety and Health at Work(3-6 Sept. 2017) in Singapore, at which over 3.000 experts from around the Globe are expected. The WCSH will be held from 6-9 September 2017 in Singapore. During the 2-hour session on “Prevention Pays! The role of accident insurance and the return to work reintegration”, scheduled for 4 September, José Hernán Alfonso and Patricia Weinert will present the challenges of OSD and call for OSD minimum standards. This is a great opportunity to give StanDerm a platform to communicate and to discuss the Action’s key concern with experts and stakeholders.   Follow: #WorldCongress2017 | @WorldCongressSH

StanDerm's grand finale

23 May 2017 | Successful final workshop 18-19 May 2017 (Berlin) with major achievements

Four years of intensive work of the COST Action TD 1206 "StanDerm" have come to an end. The final workshop was held from 18-19 May 2017 in Berlin with almost 70 participants from 21 countries at the German Social Accident Insurance (DGUV) premises.   Throughout the lifetime of the Action, the pan-European network has been growing with initially 25 countries and over time extended to 31 countries actively being involved in StanDerm. The achievements but also challenges ahead pertaining to the field of occupational skin diseases, including skin cancer, are well reflected in the presentations made by the chairs during the final event.    The position paper on the (minimum) standards on the prevention, diagnosis and management of occupational skin diseases (OSD), discussed and commented at a podium discussion with Union and Social Security representatives from Brussels, is an important outcome of the Action. It is a blueprint for how to deal with prevention and management of word-related (WRDS) and occupational skin diseases as this is still often not sufficiently followed. The paper will be published in a JEADV supplement in June 2017 and made available to all specialized physicians involved in occupational care, stakeholders, organizations and industry involved in preventing WRSD and OSD.    

Strong concerns on self-testing for contact sensitization to hair dyes

22 March 2017 | Statement by StanDerm

StanDerm expresses its concern vis-à-vis the position of the European Commission with regard to skin testing methods recommended by the manufacturers of oxidative hair dyes. Different views have been expressed and StanDerm fully supports the position taken by the hairdressing social partners (Coiffure EU and UNI Europa), namely to abandon the self-testing method and to replace it with a scientifically based questionnaire, and very importantly, to consult a dermatologist/allergologist. StanDerm adopted the following statement. In order to find out whether consumers are allergic to certain dyes and colouring substances, manufacturers recommend that a self-test is carried out before product use. In addition to the methodological and scientific concerns of the social partners on the self-test method, it appears that a significant proportion of the hairdressers applying this method are unable to interpret its results nor do they have the appropriate training made available. The social partners call for the abolition of the self-testing method.

Occupational dermatoses in Spain

09 March 2017 | Annual training course organized by Hospital del Mar in Barcelona.

For the 7th consecutive time, the Hospital del Mar in Barcelona organized under the guidance of Prof. Dr. Ana Gimenez Arnau the annual training course on occupational dermatoses with an interdisciplinary approach devoted to the various facets of this disease. Particular attention was given to the patient treatment, which involves coordinated care provided by different disciplines. Also in Spain occupational dermatoses affects about 10% of the working population, having a significant socio- economic impact, amongst others due to the reported sick leave and loss of job and/or retraining. Prevention is therefore an important requisite as emphasized during the course. Ana Gimenez Arnau also drew attention to the position paper of StanDerm on the need to standardize patient management and prevention of occupational skin diseases throughout Europe.  The paper will be published in May at the occasion of the final workshop of StanDerm (Berlin, 18-19 May).  
© StanDerm

We are up there with the best!

20 January 2017 | StanDerm contributions on OSC amongst top 20 2016 JEADV articles

Amongst the most shared and cited 2016 JEADV articles appear StanDerm´s contributions published in the JEADV supplement volume 30, S 3. The publication “Non-melanoma Skin Cancer by Solar UV. The Neglected Occupational Threat”, provides an overview and highlights new research on the current European status quo regarding epidemiology, risk assessment and UVR exposure measurement, legal management and health care services provided to affected workers. The consensus report, most shared, calls European member states to recognize NMSC as an occupational disease and the EU Commission to revise the 2006 Directive on Artificial Optical Radiation (2006/25EC) to include solar UV radiation within its scope.

Archive

Background

 

 

In Europe:

  • occupational skin diseases (OSD) represent up to 40% of occupational diseases
  • OSD related costs exceed 5 billion €/year by loss of productivity
  • there are isolated efforts of OSD prevention in some countries
  • there is no coordinated action between the stakeholders at national and international levels
  • surveillance and diagnostics of OSD are hampered by lack of common monitoring of new allergens  in workplaces. 


The EU Commission therefore defined lacking prevention of OSD a top priority problem.  

"StanDerm" comprises 31 countries and aims at coordinating activities relevant for OSD prevention, including basic sciences (aetiology and individual susceptibility), epidemiological surveillance, transnational and applied clinical research.This involves regulatory issues (e.g. REACH), development of interdisciplinary workers' education concepts, identifying individual susceptibility markers enabling tailored prevention and pre-employment counselling.  

This COST Action will allow setting up transnational controlled intervention studies in large cohorts in high-risk professions. The outcome will be evidence-based common European standards on OSD prevention and patient management. This will provide a safer working environment and targeted early intervention for workers throughout Europe, enhancing economic competitiveness, particularly of small and medium-sized enterprises (SMEs).

Memorandum of Unterstanding (MoU) is signed by the participating governments of the COST countries. The MoU details the content, the arrangement and related activities for the implementation of the Action.